Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myelomaBruno Paiva, Martín Pérez‐Andrés, María‐Belén Vídriales et al.|Leukemia|2011Cited by 91
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJoaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio et al.|Leukemia|2017Cited by 51
A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.MV Mateos, Jesús F. San Miguel, Joan Bladé et al.|Blood|2004Cited by 39
P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1Joaquín Martínez‐López, A. Krishnan, Albert Oriol et al.|HemaSphere|2022Cited by 3